Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy

This publication has 16 references indexed in Scilit:

• Characterization of the Novel Human Serotonin Receptor Subunits 5-HT3C,5-HT3D, and 5-HT3E
  Molecular Pharmacology, 2007
• American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006
  Journal of Clinical Oncology, 2006
• Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer
  The Lancet Oncology, 2004
• Investigation of the association between 5-HT3A receptor gene polymorphisms and efficiency of antiemetic treatment with 5-HT3 receptor antagonists
  Pharmacogenetics, 2004
• Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E
  Gene, 2003
• Molecular, pharmacological and functional diversity of 5-HT receptors
  Published by Elsevier ,2002
• Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting
  Cancer, 2000
• The Pharmacological and Functional Characteristics of the Serotonin 5-HT3A Receptor Are Specifically Modified by a 5-HT3B Receptor Subunit
  Published by Elsevier ,1999
• The 5-HT3B subunit is a major determinant of serotonin-receptor function
  Nature, 1999
• Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species.
  1995